At each visit: Weight and body composition measurements Blood pressure and heart rate Appetite and appetite suppression assessment GI tolerance and other side effects Medication adherence and injection technique Protein intake and exercise consistency Laboratory monitoring occurs at Month 3 (comprehensive panel), Month 6, and Month 12, then annually
6,7 Importantly, Berberine may interact adversely with hypoglycemic medications, potentially causing excessive lowering of blood glucose levels, and it can also interact with antibiotics
This is the core pharmacological rationale for the triple agonist design
Some people stop taking GLP-1 medications and maintain their results
To help you manage your intake effectively, our GLP-1 app can guide you in tracking your protein intake and optimizing your nutrition
RT exposure during transport acceptable